Real-time enrollment status for this recessive dystrophic epidermolysis bullosa clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 12:24 PM UTC
| NCT Number | NCT07700966 |
| Recruiting Status | Recruiting |
| Condition | Recessive Dystrophic Epidermolysis Bullosa |
| Phase | Clinical Trial |
| Target Enrollment | 250 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Abeona Therapeutics, Inc |
| Last Updated on CT.gov | July 14, 2026 (5 days ago) |
As of July 19, 2026: Clinical trial NCT07700966 is currently recruiting participants. This clinical trial study for recessive dystrophic epidermolysis bullosa is actively seeking new participants at 4 locations across the United States. The study is sponsored by Abeona Therapeutics, Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07700966 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07700966 was last updated 5 days ago (July 14, 2026). HelloStudys verifies this status automatically.